LEDERMAN SETH 4
4 · Tonix Pharmaceuticals Holding Corp. · Filed Feb 27, 2025
Insider Transaction Report
Form 4
LEDERMAN SETH
DirectorChief Executive Officer
Transactions
- Other
Common Stock, $0.001 par value
2025-02-05$0.15/sh−1$0→ 0 total(indirect: By Spouse) - Other
Common Stock, $0.001 par value
2025-02-05$3.38/sh−5.18$18→ 5 total - Other
Common Stock, $0.001 par value
2025-02-05$3.30/sh−0.22$1→ 1 total(indirect: By IRA) - Award
Stock Option
2025-02-25+123,958→ 123,958 totalExercise: $8.05From: 2026-02-25Exp: 2035-02-25→ Common Stock (123,958 underlying) - Award
Stock Option
2025-02-25+123,958→ 123,958 totalExercise: $10.06From: 2026-02-25Exp: 2035-02-25→ Common Stock (123,958 underlying)
Holdings
- 1(indirect: Lederman & Co.)
Common Stock, $0.001 par value
- 1(indirect: By IRA)
Common Stock, $0.001 par value
- 5
Common Stock, $0.001 par value
Footnotes (4)
- [F1]Reporting person may be deemed to be a control person of this entity.
- [F2]Involuntary sale of fractional share following a reverse stock split of the Issuer's common stock.
- [F3]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
- [F4]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.